The North American experience with photopheresis

Therapeutic Apheresis

Volumn 3, Issue 1, 1999, Pages 50-62

  Zic, John A ^a,b   Miller, Jami L ^a   Stricklin, George P ^a   King Jr , Lloyd E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Extracorporeal photochemotherapy; Immunomodulation; Photopheresis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; ETRETINATE; GOLD; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHOXSALEN; OKT 3; PREDNISONE; TACROLIMUS; TRIAMCINOLONE; UNCLASSIFIED DRUG; UVADEX;

ARTICLE; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; DERMATOMYOSITIS; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYME DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; RHEUMATOID ARTHRITIS; SCLERODERMA; SKIN LYMPHOMA; T CELL LYMPHOMA; TOPICAL DRUG ADMINISTRATION;

ARTHRITIS, RHEUMATOID; GRAFT VS HOST DISEASE; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; METHOXSALEN; NORTH AMERICA; PHOTOPHERESIS; PHOTOSENSITIZING AGENTS; SCLERODERMA, SYSTEMIC;

EID: 0033008646     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.1999.00142.x     Document Type: Article

References (90)

1. Heymans JF. Iso, hyper et hypothermisation des mammiferes par calorification et frigorification du sang de la circulation carotid-jugulaire anastomosee. Arch Int Pharmacodyn 1921; 25:1-5.
2. Cronkite EP. Extracorporeal irradiation of the blood and lymph in the treatment of leukemia and for immunosuppression. Ann Intern Med 1967;67:415-23.
3. Cronkite EP, Jansen CR, Mather GC, Nielsen L, Usenik EA, Adamik ER, Sipe CR. Studies on lymphocytes. I. Lymphopenia produced by prolonged extracorporeal irradiation of the circulation of the blood. Blood 1962;20;203-8.
4. Schiffer LM, Chanana AD, Cronkite EP, Greenberg ML, Joel DD, Schnappauf H, Stryckmans PA. Extracorporeal irradiation of the blood. Semin Hematol 1966;3:154-67.
5. Schiffer LM. Abstracts of papers read at an international symposium on 'extracorporeal irradiation of blood' held at the Weizmann Institute of Science, Rehovoth, Israel on May 17-19, 1969. Br J Haematol 1969;17:405-15.
6. Binet JL, Van Rapenbush R, Villeneuve B, Becard R, Bernard J. Effects of ultraviolet irradiation on the lymphocytes in the blood. Inhibition of uridine incorporation (translation from French). Comptes Rendus Hebdomadaires des Seances de l Academie des Sciences - D: Sciences Naturelles 1967;265: 173-6.
7. Binet JL, Villeneuve B, Rapenbusch Rv, Mignon F, Becard R, Vaugier G, Bernard J. Extracorporeal radiation of the blood by ultraviolet rays (translation from French). Nouv Rev Fr Hematol 1968;8:733-44.
8. Binet JL, Vaugier G, Villeneuve B, Bernard J. Comparison of the action of ionizing and ultra-violet radiation on lymphocytes in vitro. Br J Haematol 1969;17:410.
9. Villeneuve B, Binet JL, Becart R, Bernard J. Lymphocyte circulation in the goat. Time of passage of lymphocytes from the blood into the efferent popliteal lymph duct and effect of extracorporeal ultraviolet radiation on this circulation (translation from French). Nouv Rev Fr Hematol 1968;8:535-40.
10. Binet JL, Villeneuve B, Vaugier G, Bernard J. Extracorporeal irradiation of blood by ultra-violet light in four cases of chronic lymphocytic leukaemia. Br J Haematol 1969;17:406.
11. Binet JL. Treatment of chronic lymphocytic leukaemia. French Co-operative Group on CLL. Bailliere's Clin Haematol 1993;6:867-78.
12. Edelson RL. Light-activated drugs. Sci Am 1988;259:68-75.
13. Edelson RL. Recent advances in the cutaneous T cell lymphomas. Bull Cancer 1977;64:209-24.
14. Gilchrest BA, Parrish JA, Tanenbaum L, Haynes HA, Fitzpatrick TB. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 1976;38:683-9.
15. Gilchrest BA. Methoxsalen photochemotherapy for mycosis fungoides. Cancer Treat Rep 1979;63:663-7.
16. Cruz PD. Cutaneous T-cell lymphoma: Advances in tandem with immunologic breakthroughs. Dermatol Focus 1997; Spring:1-5.
17. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, Vonderheid E, Knobler R, Wolff K, Plewig G. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. New Engl J Med 1987;316:297-303.
18. Knobler RM, Trautinger F, Graninger W, Macheiner W, Gruenwald C, Neumann R, Ramer W. Parenteral administration of 8-methoxypsoralen in photopheresis. J Am Acad Dermatol 1993;28:580-4.
19. Lutzner M, Edelson R, Schein P, Green I, Kirkpatrick C, Ahmed A. Cutaneous T-cell lymphomas: The Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med 1975;83:534-52.
20. Edelson RL. Cutaneous T-cell lymphomas: Clues of a skinthymus interaction. J Invest Dermatol 1976;67:419-24.
21. Hoppe RT, Wood GS, Abel EA. Mycosis fungoides and the Sézary syndrome: Pathology, staging, and treatment. Curr Probl Cancer 1990;14:293-371.
22. Edelson RL. Cutaneous T cell lymphoma: Mycosis fungoides, Sézary syndrome, and other variants. J Am Acad Dermatol 1980;2:89-106.
23. Diamandidou E, Cohen PR, Kurzrock R. Mycosis fungoides and Sézary syndrome. Blood 1996;88:2385-409.
24. Bazin E. Lecons sur le Traitement des Maldies Chroniques en General affections de la Peau en Particular par l'Emploi Compare des Eaux Minerales de l'Hydrotherapie et des Moyens Pharmaceutiques. Paris: Adrien Delahaye, 1870.
25. Broder S, Bunn PA Jr. Cutaneous T-cell lymphomas. Semin Oncol 1980;7:310-31.
26. Koh HK, Charif M, Weinstock MA. Epidemiology and clinical manifestations of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995;9:943-60.
27. King LE Jr, Dufresne RG Jr, Lovett GL, Rosin MA. Erythroderma: Review of 82 cases. South Med J 1986;79:1210-5.
28. Buechner SA, Winkelmann RK. Sézary syndrome. A clinicopathologic study of 39 cases. Arch Dermatol 1983;119:979-86.
29. Wieselthier JS, Koh HK. Sézary syndrome: Diagnosis, prognosis, and critical review of treatment options. J Am Acad Dermatol 1990;22:381-401.
30. Zic J, Arzubiaga C, Salhany KE, Parker RA, Wilson D, Stricklin GP, Greer J, King LE Jr. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 1992;27:729-36.
31. Marschalko M, Knobler R, Soos G, Berecz M, Paloczy K, Racz I. Extracorporeal photopheresis in the therapy of Sézary syndrome (translation from French). Orv Hetil 1993;134: 1253-7.
32. Prinz B, Behrens W, Holzle E, Plewig G. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma - the Dusseldorf and Munich experience. Arch Dermatol Res 1995;287:621-6.
33. Fimiani M, Rubegni P, G DA, Andreassi L. Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma (letter and comment). J Am Acad Dermatol 1994;31:828-30.
34. Owsianowski M, Garbe C, Ramaker J, Orfanos CE, Gollnick H. Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases (translation from German). Hautarzt 1996;47: 114-23.
35. Bohmeyer J, Otte HG, Stadler R. Therapy of Sézary syndrome with extracorporeal photochemotherapy (translation from German). Hautarzt 1996;47:24-8.
36. Heald PW, Perez MI, Christensen I, Dobbs N, McKiernan G, Edelson R. Photopheresis therapy of cutaneous T-cell lymphoma: The Yale-New Haven Hospital experience. Yale J Biol Med 1989;62:629-38.
37. Armus S, Keyes B, Cahill C, Berger C, Crater D, Scarborough D, Klainer A, Bisaccia E. Photopheresis for the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol 1990;23: 898-902.
38. Oziemski MA, Rockman SP, Marks DI, Green MD, Varigos GA, Fox RM. Extracorporeal photochemotherapy in the treatment of cutaneous T-cell lymphoma. Complexity of objective evaluation. Int J Dermatol 1991;30:814-7.
39. Koh HK, Davis BE, Meola T, Lim HW. Extracorporeal photopheresis for the treatment of 34 patients with cutaneous T cell lymphoma (CTCL). J Invest Dermatol 1994;102:567.
40. Duvic M, Hagemeister F, Hester J. Accelerated delivery of extracorporeal photopheresis in patients with cutaneous T-cell lymphoma. J Invest Dermatol 1989;92:423.
41. Duvic M, Hester JP, Lemark NA. Photopheresis therapy for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 1996;35:573-9.
42. Gottlieb SL, Wolfe JT, Fox FE, DeNardo BJ, Macey WH, Bromley PG, Lessin SR, Rook AH. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alpha: A 10-year experience at a single institution. J Am Acad Dermatol 1996;35:946-57.
43. Vonderheid EC, Zhang Q, Lessin SR, Polansky M, Abrams JT, Bigler RD, Wasik MA. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma. J Am Acad Dermatol 1998;38:207-20.
44. Fraser-Andrews E, Seed P, Whittaker S, Russell Jones R. Extracorporeal photopheresis in Sézary syndrome. Arch Dermatol 1998;134:1001-5.
45. Lim HW, Edelson RL. Photopheresis for the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995;9:1117-26.
46. Zic JA, Stricklin GP, Greer JP, Kinney MC, Shyr Y, Wilson DC, King LE Jr. Long-term follow-up of cutaneous T-cell lymphoma patients treated with extracorporeal photochemotherapy. J Am Acad Dermatol 1996;35:935-45.
47. Heald P, Rook A, Perez M, Wintroub B, Knobler R, Jegasothy B, Gasparro F, Berger C, Edelson R. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 1992;27:427-33.
48. Bunn PA Jr, Hoffman SJ, Norris D, Golitz LE, Aeling JL. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome). Ann Intern Med 1994; 121:592-602.
49. Lim HW, Harris HR. Etretinate as an effective adjunctive therapy for recalcitrant palmar/plantar hyperkeratosis in patients with erythrodermic cutaneous T cell lymphoma undergoing photopheresis. Dermatol Surgery 1995;21:597-9.
50. Rook AH, Prystowsky MB, Cassin M, Boufal M, Lessin SR. Combined therapy for Sézary syndrome with extracorporeal photochemotherapy and low-dose interferon alpha therapy. Clinical, molecular, and immunologic observations. Arch Dermatol 1991;127:1535-40.
51. Vonderheid EC, Bigler RD, Greenberg AS, Neukum SJ, Micaily B. Extracorporeal photopheresis and recombinant interferon alpha 2b in Sézary syndrome. Use of dual marker labeling to monitor therapeutic response. Am J Clin Oncol 1994;17:255-63.
52. Wolfe JT, Lessin SR, Singh AH, Rook AH. Review of immunomodulation by photopheresis: Treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. Artif Organs 1994;18:888-97.
53. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: Relevance to mechanism of therapeutic action. J Invest Dermatol 1996;107:235-42.
54. Berger CL, Wang N, Christensen I, Longley J, Heald P, Edelson RL. The immune response to class 1-associated tumor-specific cutaneous T-cell lymphoma antigens. J Invest Dermatol 1996;107:392-7.
55. Moor AC, Schmitt IM, Beijersbergen van Henegouwen GM, Chimenti S, Edelson RL, Gasparro FP. Treatment with 8-MOP and UVA enhances MHC class 1 synthesis in RMA cells: Preliminary results. J Photochem Photobiol B Biol 1995;29:193-8.
56. Rook AH, Wolfe JT. Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. J Clin Apheresis 1994;9:28-30.
57. Perez M, Edelson R, Laroche L, Berger C. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. J Invest Dermatol 1989;92:669-76.
58. Vowels BR, Cassin M, Boufal MH, Walsh LJ, Rook AH. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: Implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 1992;98:686-92.
59. Edelson RL, Heald P, Perez M, Berger C. Extracorporeal photochemotherapy. Biol Ther Cancer Updates 1994;4:1-12.
60. Khavari PA, Edelson RL, Lider O, Gasparro FP, Weiner HL, Cohen IR. Specific vaccination against photoinactivated cloned T cells. Clin Res 1988;36:662.
61. Miracco C, Rubegni P, De Aloe G, D'Ascenzo G, Mazzatenta C, De Santi MM, Fimiani M. Extracorporeal photochemotherapy induces apoptosis of infiltrating lymphoid cells in patients with mycosis fungoides in early stages. A quantitative histological study. Br J Dermatol 1997;137:549-57.
62. Fimiani M, Rubegni P, Pimpinelli N, Mori M, De Aloe G, Andreassi L. Extracorporeal photochemotherapy induces a significant increase in CD36+ circulating monocytes in patients with mycosis fungoides. Dermatol 1997;194:107-10.
63. Di Renzo M, Rubegni P, De Aloe G, Paulesu L, Pasqui AL, Andreassi L, Auteri A, Fimiani M. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma. Immunol 1997;92:99-103.
64. Lazarus HM, Vogelsang GB, Rowe JM. Prevention and treatment of acute graft-versus-host disease: The old and the new. A report from the Eastern Cooperative Oncology Group (ECOG). Bone Marrow Transplant 1997;19:577-600.
65. Ringden O. Allogeneic bone marrow transplantation for hematological malignancies-controversies and recent advances. Acta Oncol 1997;36:549-64.
66. Lamparelli T, Van Lint MT, Gualandi F, Occhini D, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Ferrara GB, Delfino L, Pozzi S, Morabito A, Zikos P, Vitale V, Corvo R, Frassoni F, Bacigalupo A. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: Single center experience. Bone Marrow Transplant 1997;20:1057-62.
67. Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 1994;14:845-8.
68. Richter HI, Stege H, Ruzicka T, Soehngen D, Heyll A, Krutmann J. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease. J Am Acad Dermatol 1997;36:787-9.
69. Dall'Amico R, Rossetti F, Zulian F, Montini G, Murer L, Andreetta B, Messina C, Baraldi E, Montesco MC, Dini G, Locatelli F, Argiolu F, Zacchello G. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol 1997;97:848-54.
70. Rossetti F, Zulian F, Dall'Amico R, Messina C, Montini G, Zacchello F. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease. Transplantation 1995;59:149-51.
71. Dall'Amico R, Zacchello G. Treatment of graft-versus-host disease with photopheresis (letter and comment). Transplantation 1998;65:1283-4.
72. Gerber M, Gmeinhart B, Volc-Platzer B, Kalhs P, Greinix H, Knobler R. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP). Bone Marrow Transplant 1997;19:517-9.
73. Costanzo-Nordin MR, McManus BM, Wilson JE, OSullivan, EJ, Hubbell EA, Robinson JA. Efficacy of photopheresis in the rescue therapy of acute cellular rejection in human heart allografts: A preliminary clinical and immunopathologic report. Transplant Proc 1993;25:881-3.
74. Barr ML, Meiser BM, Eisen HJ, Roberts RF, Livi U, Dall'Amico R, Dorent R, Rogers JG, Radovancevic B, Taylor DO, Jeevanandam V, Marboe CC. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 1998;339:1744-51.
75. Wolfe JT, Tomaszewski JE, Grossman RA, Gottlieb SL, Naji A, Brayman KL, Kobrin SM, Rook AH. Reversal of acute renal allograft rejection by extracorporeal photopheresis: A case presentation and review of the literature. J Clin Apheresis 1996;11:36-41.
76. Slovis BS, Loyd JE, King LE, Jr. Photopheresis for chronic rejection of lung allografts (letter). N Engl J Med 1995;332:962.
77. Rook AH, Freundlich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, Rietschel RL, Wintroub B, Kahaleh MB, Varga J, Heald P, Steen V, Massa MC, Murphy GF, Perniciaro C, Istfan M, Ballos SK, Edelson RL. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol 1992;128:337-46.
78. Di Spaltro FX, Cottrill C, Cahill C, Degnan E, Mulford GJ, Scarborough D, Franks AJ Jr, Klainer AS, Bisaccia E. Extracorporeal photochemotherapy in progressive systemic sclerosis, Int J Dermatol 1993;32:417-21.
79. Malawista SE, Trock DH, Edelson RL. Treatment of rheumatoid arthritis by extracorporeal photochemotherapy. A pilot study. Arthritis Rheum 1991;34:646-54.
80. De Wilde A, DiSpaltro FX, Geller A, Szer IS, Klainer AS, Bisaccia E. Extracorporeal photochemotherapy as adjunctive treatment in juvenile dermatomyositis: A case report (letter). Arch Dermatol 1992;128:1656-7.
81. Rook AH, Jegasothy BV, Heald P, Nahass GT, Ditre C, Witmer WK, Lazarus GS, Edelson RL. Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 1990;112:303-5.
82. Miller JL, Stricklin GP, Fine JD, King LE, Arzubiaga MC, Ellis DL. Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy. Br J Dermatol 1995;133:467-71.
83. Gordon KB, Chan LS, Woodley DT. Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy. Br J Dermatol 1997;136:415-20.
84. Vonderheid EC, Kang CA, Kadin M, Bigler RD, Griffin TD, Rogers TJ. Extracorporeal photopheresis in psoriasis vulgaris: Clinical and immunologic observations. J Am Acad Dermatol 1990;23:703-12.
85. Berkson M, Lazarus GS, Uberti-Benz M, Rook AH. Extracorporeal photochemotherapy: A potentially useful treatment for scleromyxedema. J Am Acad Dermatol 1991;25:724.
86. Wieselthier JS, Rothstein TL, Yu TL, Anderson T, Japowicz MC, Koh HK. Inefficacy of extracorporeal photochemotherapy in the treatment of B-cell chronic lymphocytic leukemia: Preliminary results. Am J Hematol 1992;41:123-7.
87. Randazzo JP, DiSpaltro FX, Cottrill C, Klainer AS, Steere AC, Bisaccia E. Successful treatment of a patient with chronic Lyme arthritis with extracorporeal photochemotherapy. J Am Acad Dermatol 1994;30:908-10.
88. Bisaccia E, Berger C, Klainer AS. Extracorporeal photopheresis in the treatment of AIDS-related complex: A pilot study. Ann Intern Med 1990;113:270-5.
89. Bisaccia E, Berger C, DiSpaltro FX, Klainer AS. Extracorporeal photopheresis in the treatment of AIDS-related complex: Extended trial. J AIDS 1993;6:386-92.
90. Gonzalez J, Berger C, Cottrill CM, Geller A, Schwartz J, Palangio M, Klainer AS, Bisaccia E. Cytolytic response to HIV in patients with HIV disease treated with extracorporeal photochemotherapy: Preliminary study. Photochem Photobiol 1996;63:558-61.